| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/13/2005 | EP1552289A2 A method to quantitatively analyze conjugated dienes in hydrocarbon feeds and products as an indicator of fouling potential |
| 07/13/2005 | EP1552288A1 A freshness indicator of foodstuffs |
| 07/13/2005 | EP1552286A1 Column for analytical temperature rising elution fractionation (atref) |
| 07/13/2005 | EP1552284A2 Electrochemiluminescence flow cell and flow cell components |
| 07/13/2005 | EP1552276A1 A disposable cartridge for characterizing particles suspended in a liquid |
| 07/13/2005 | EP1552272A2 Formation of metal nanowires for use as variable-range hydrogen sensors |
| 07/13/2005 | EP1552270A2 Buffy coat separator float system and method |
| 07/13/2005 | EP1552269A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 07/13/2005 | EP1552267A2 Serum transfer cup |
| 07/13/2005 | EP1552228A2 Method for identifying thawed and refrozen products |
| 07/13/2005 | EP1552025A2 Processes for identifying quadruplex-targeted antiviral molecules |
| 07/13/2005 | EP1552024A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 07/13/2005 | EP1552023A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 07/13/2005 | EP1552021A1 Type i interferon-inducible proteins to detect viral infection |
| 07/13/2005 | EP1552019A2 Cancer diagnostics and prognostics |
| 07/13/2005 | EP1552017A1 Apparatus and methods for detecting dna in biological samples |
| 07/13/2005 | EP1552012A2 Susceptibility gene for human stroke; methods of treatment |
| 07/13/2005 | EP1552011A2 Photonic signal reporting of electrochemical events |
| 07/13/2005 | EP1552010A2 Strategies for gene expression analysis |
| 07/13/2005 | EP1552008A1 Microparticle based signal amplification for the detection of analytes |
| 07/13/2005 | EP1552003A1 Methods to assess quality of microarrays |
| 07/13/2005 | EP1551994A2 Means of detecting neurodegenerative processes and applications of same |
| 07/13/2005 | EP1551991A2 Functional cardiomyocytes from human embryonic stem cells |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551979A2 Compositions and methods for treatment and detection of multiple cancers |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551965A2 Short enzyme donor fragment |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551962A2 Mitotic kinesin binding site |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551866A1 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a thioredoxin-like 32 kda protein |
| 07/13/2005 | EP1551857A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 07/13/2005 | EP1551855A2 Altering memory by affecting staufen function |
| 07/13/2005 | EP1551627A2 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 07/13/2005 | EP1551460A1 A method for monitoring the effectiveness of tetracycline in the treatment of asthma |
| 07/13/2005 | EP1551456A1 Pharmaceutical composition for prevention and treatment of kidney diseases |
| 07/13/2005 | EP1551450A1 Markers of blood barrier permeability and methods of using same |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/13/2005 | EP1551443A2 Proteins involved in the regulation of energy homeostasis |
| 07/13/2005 | EP1551439A2 Improved systems and methods for analysis of protein post-translational modification |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551383A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 07/13/2005 | EP1551291A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 07/13/2005 | EP1551229A1 Method and arrangement related to a dough forming |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP1488002A4 Methods to increase nucleotide signals by raman scattering |
| 07/13/2005 | EP1451341A4 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 07/13/2005 | EP1417481A4 Method of analyzing nucleated red blood cells in a blood sample |
| 07/13/2005 | EP1383923A4 High-fidelity dna sequencing using solid phase capturable dideoxynucleotides and mass spectrometry |
| 07/13/2005 | EP1315695B1 Benzene tricarboxylic acid amides as insulin receptor activators |
| 07/13/2005 | EP1292700A4 Enzyme detection and measurement |
| 07/13/2005 | EP1266039B1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 07/13/2005 | EP1202060B1 Biosensor and method for its preparation |
| 07/13/2005 | EP1036332B1 Multiple assay method |
| 07/13/2005 | EP1021722B1 Improvements in or relating to screening for papilloma viruses |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN2709981Y Detection device for fall-down degree of mixer car concrete |
| 07/13/2005 | CN1639575A In vitro model for priocidal activity |
| 07/13/2005 | CN1639574A Serological assay for neospora caninum |
| 07/13/2005 | CN1639573A Test device |
| 07/13/2005 | CN1639572A Assay for anti-INGAP antibodies |
| 07/13/2005 | CN1639571A Population based assessments and means to rank the relative immunogenicity of proteins |
| 07/13/2005 | CN1639568A Support for ligand immobilization |
| 07/13/2005 | CN1639567A Drift compensated magnetic permeability detector |
| 07/13/2005 | CN1639566A Therapeutic properties of oils |
| 07/13/2005 | CN1639565A A method of measuring the concentration of hydrogen and methane in nitrogen by means of ion mobility spectrometry |
| 07/13/2005 | CN1639564A Analyzer having information recognizing function, analytic tool for use therein, and unit of analyzer and analytic tool |
| 07/13/2005 | CN1639562A Measurement instrument, measurement tool storage case and operation mechanism |
| 07/13/2005 | CN1639561A Measurement instrument |
| 07/13/2005 | CN1639558A Fluid analyser systems |
| 07/13/2005 | CN1639557A Multi-parameter assays including analysis discs and methods relating thereto |
| 07/13/2005 | CN1639555A 样品测试装置 Sample testing device |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639357A Method for detecting human papillomarvirus mRNA |
| 07/13/2005 | CN1639355A Double and triple readout assay systems |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639334A Novel method of highly sensitive nucleic acid analysis |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1639316A Reaction cell and method of using the cell |
| 07/13/2005 | CN1639206A Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1639191A 鼠李糖结合蛋白 Rhamnose-binding protein |
| 07/13/2005 | CN1639185A Cancer-associated epitope |
| 07/13/2005 | CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638790A Compositions and methods for modulating connexin hemichannels |
| 07/13/2005 | CN1638781A Carbon monoxide as a biomarker and therapeutic agent |
| 07/13/2005 | CN1638758A Stimulation of CPT-1 as a means to reduce weight |
| 07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
| 07/13/2005 | CN1637417A Active transcription factor detecting method and kit |
| 07/13/2005 | CN1637416A Fp-ghrelin |
| 07/13/2005 | CN1637408A Correction method for the distribution of quantity of light and biochip-reader |
| 07/13/2005 | CN1637405A Biochip substrate holding method and biochip-reader |
| 07/13/2005 | CN1637395A Maintenance-free high-performance syringe |
| 07/13/2005 | CN1637155A Device and method for printing biomolecules onto substrate using electrohydrodynamic effect |